RESUMO
There is accumulating evidence from observational and intervention studies in nutritional psychiatry regarding the importance of diet for mental health outcomes across the lifespan. Here, we synthesise this evidence, including findings from large meta-analyses showing cross-sectional and prospective associations between diet quality and mental health, even following adjustment for relevant confounding factors. Potential mechanistic pathways underpinning these associations include those of the gut-brain axis, demonstrated mostly in animal models. Dietary fibre is an important component of healthy diet and may be relevant for common mental disorders, with some studies showing a dose-dependent relationship between fibre intake and risk of depression. The potential contribution of nutraceuticals is also discussed, such as omega-3 fatty acids, vitamins, minerals, and psychobiotics. We consider the relevance of special diets such as the ketogenic diet and food sensitivities in the management of severe mental illness (e.g., anorexia nervosa) and brain disease (e.g., Alzheimer's disease). Given the relatively early nature of research in nutritional psychiatry, there remain a number of challenges to its translation into clinical practice. These span individual, clinical, and societal domains. We conclude with a discussion of micro- and macroeconomic factors which may be considered in the successful application of nutritional psychiatry research to improve public health.
Assuntos
Dieta/psicologia , Comportamento Alimentar , Saúde Mental , Fenômenos Fisiológicos da Nutrição , Animais , Fibras na Dieta , Suplementos Nutricionais , Comportamento Alimentar/fisiologia , Comportamento Alimentar/psicologia , Humanos , Psiquiatria/tendências , PsicofisiologiaRESUMO
OBJECTIVE: The Australian federal government introduced new COVID-19 psychiatrist Medicare Benefits Schedule (MBS) telehealth items to assist with providing private specialist care. We investigate private psychiatrists' uptake of video and telephone telehealth, as well as total (telehealth and face-to-face) consultations for Quarter 3 (July-September), 2020. We compare these to the same quarter in 2019. METHOD: MBS-item service data were extracted for COVID-19-psychiatrist video and telephone telehealth item numbers and compared with Quarter 3 (July-September), 2019, of face-to-face consultations for the whole of Australia. RESULTS: The number of psychiatry consultations (telehealth and face-to-face) rose during the first wave of the pandemic in Quarter 3, 2020, by 14% compared to Quarter 3, 2019, with telehealth 43% of this total. Face-to-face consultations in Quarter 3, 2020 were only 64% of the comparative number of Quarter 3, 2019 consultations. Most telehealth involved short telephone consultations of ⩽15-30 min. Video consultations comprised 42% of total telehealth provision: these were for new patient assessments and longer consultations. These figures represent increased face-to-face consultation compared to Quarter 2, 2020, with substantial maintenance of telehealth consultations. CONCLUSIONS: Private psychiatrists continued using the new COVID-19 MBS telehealth items for Quarter 3, 2020 to increase the number of patient care contacts in the context of decreased face-to-face consultations compared to 2019, but increased face-to-face consultations compared to Quarter 2, 2020.
Assuntos
COVID-19/prevenção & controle , Transtornos Mentais/terapia , Serviços de Saúde Mental/tendências , Padrões de Prática Médica/tendências , Prática Privada/tendências , Psiquiatria/tendências , Telemedicina/tendências , Assistência Ambulatorial/métodos , Assistência Ambulatorial/organização & administração , Assistência Ambulatorial/tendências , Austrália , COVID-19/epidemiologia , Utilização de Instalações e Serviços/tendências , Acessibilidade aos Serviços de Saúde/organização & administração , Acessibilidade aos Serviços de Saúde/tendências , Humanos , Serviços de Saúde Mental/organização & administração , Programas Nacionais de Saúde , Pandemias , Padrões de Prática Médica/organização & administração , Prática Privada/organização & administração , Psiquiatria/organização & administração , Telemedicina/métodos , Telemedicina/organização & administração , Telefone/tendências , Comunicação por Videoconferência/tendênciasRESUMO
The Covid-19 pandemic has a major impact on psychiatry by its social consequences and possible direct effect of certain forms of Covid-19 on mental health. During this crisis, the accessibility of technology meets a state of necessity, which has propelled telepsychiatry from the shadows into the light. The contribution of several technologies (i.e. virtual reality, actigraphy, computational psychiatry) combining clinical data and neuroscience underlines the great neurobehavioural variability even within the same diagnostic category, calling for greater precision in therapeutic offers as suggested e.g. by developments in neurofeedback. The place of intranasal esketamin in the panoply of antidepressent drug treatments for resistant depression has not yet been defined.
La pandémie de Covid-19 bouleverse la psychiatrie par ses conséquences sociales et par de possibles séquelles psychiatriques. La crise actuelle révèle l'accessibilité de technologies digitales telles que la télépsychiatrie. Des technologies comme la réalité virtuelle, l'actigraphie, la psychiatrie computationnelle combinées aux données cliniques et aux neurosciences révèlent une importante variabilité neurocomportementale même au sein d'une catégorie diagnostique donnée, invitant à une plus grande précision des traitements comme suggéré par les recherches en neurofeedback. La place de l'eskétamine intranasale dans la panoplie thérapeutique médicamenteuse de la dépression résistante doit encore être définie.
Assuntos
Psiquiatria/tendências , Telemedicina , COVID-19 , Transtorno Depressivo Resistente a Tratamento/tratamento farmacológico , Humanos , Ketamina/administração & dosagem , Neurorretroalimentação , PandemiasRESUMO
OBJECTIVE: The Australian Commonwealth Government introduced new psychiatrist Medicare-Benefits-Schedule (MBS)-telehealth items in the first wave of the COVID-19 pandemic to assist with previously office-based psychiatric practice. We investigate private psychiatrists' uptake of (1) video- and telephone-telehealth consultations for Quarter-2 (April-June) of 2020 and (2) total telehealth and face-to-face consultations in Quarter-2, 2020 in comparison to Quarter-2, 2019 for Australia. METHODS: MBS item service data were extracted for COVID-19-psychiatrist-video- and telephone-telehealth item numbers and compared with a baseline of the Quarter-2, 2019 (April-June 2019) of face-to-face consultations for the whole of Australia. RESULTS: Combined telehealth and face-to-face psychiatry consultations rose during the first wave of the pandemic in Quarter-2, 2020 by 14% compared to Quarter-2, 2019 and telehealth was approximately half of this total. Face-to-face consultations in 2020 comprised only 56% of the comparative Quarter-2, 2019 consultations. Most telehealth provision was by telephone for short consultations of ⩽15-30 min. Video consultations comprised 38% of the total telehealth provision (for new patient assessments and longer consultations). CONCLUSIONS: There has been a flexible, rapid response to patient demand by private psychiatrists using the new COVID-19-MBS-telehealth items for Quarter-2, 2020, and in the context of decreased face-to-face consultations, ongoing telehealth is essential.
Assuntos
COVID-19/prevenção & controle , Utilização de Instalações e Serviços/tendências , Serviços de Saúde Mental/tendências , Padrões de Prática Médica/tendências , Prática Privada/tendências , Psiquiatria/tendências , Telemedicina/tendências , Austrália/epidemiologia , COVID-19/epidemiologia , Utilização de Instalações e Serviços/organização & administração , Acessibilidade aos Serviços de Saúde/organização & administração , Humanos , Serviços de Saúde Mental/organização & administração , Programas Nacionais de Saúde , Pandemias , Padrões de Prática Médica/organização & administração , Prática Privada/organização & administração , Psiquiatria/métodos , Psiquiatria/organização & administração , Telemedicina/métodos , Telemedicina/organização & administração , Telefone , Comunicação por VideoconferênciaRESUMO
A growing body of data has accumulated in the past decades about the possible role of nutritional factors in influencing the initiation and course of mental disorders as well as in the treatment of these disorders. As a result of the aggregation of this data a new field emerged - "nutritional psychiatry". In our current review paper we discuss some of those natural agents that supposedly have antidepressive properties and, accordingly, may play a role in the stand-alone and/or adjuvant treatment of major depressive disorder.
Assuntos
Transtorno Depressivo Maior/dietoterapia , Estado Nutricional , Psiquiatria/métodos , Psiquiatria/tendências , HumanosRESUMO
The field of 'nutritional psychiatry' has evolved with rapidity over the past several years, with an increasing amount of dietary or nutrient-based (nutraceutical) intervention studies being initiated, and more preclinical and epidemiological data being available. This emergent paradigm involves the clinical consideration (where appropriate) of prescriptive dietary modification/improvement, and/or the select judicious use of nutrient-based supplementation to prevent or manage psychiatric disorders. In the last several years, significant links have increasingly been established between dietary quality and mental health (although not all data are supportive). Maternal and early-life nutrition may also affect the mental health outcomes in offspring. In respect to nutraceutical research, like with many recent conventional drug studies, results are fairly mixed across the board, and in many cases there is not emphatic evidence to support the use of nutraceuticals in various psychiatric disorders. This may in part be due to a preponderance of recent studies within the field revealing marked placebo effects. Due to current indicators pointing towards mental disorders having an increasing burden of disease, bold and innovative approaches on a societal level are now required. In light of the widespread use of nutrient supplements by those with and without mental disorders, it is also critical that scientifically rigorous methodologies be brought to bear on the assessment of the efficacy of these supplements, and to determine if, or what dose of, a nutrient supplement is required, for whom, and when, and under what circumstances. More simple studies of additional isolated nutrients are not of great benefit to the field (unless studied in supra-dosage in an individualised, biomarker-guided manner), nor, based on recent data, is the research of 'shotgun' formulations of nutraceuticals. The next critical step for the field is to design psychiatric interventional studies for both dietary modification and nutraceuticals, based on more of a personalised medicine approach, using biomarkers (e.g. nutrient deficiencies, inflammatory cytokine levels, genomic assessment, microbiome analysis) and a person's dietary patterns and individual macro/micronutrient requirements.
Assuntos
Comportamento Alimentar/fisiologia , Transtornos Mentais/terapia , Saúde Mental , Ciências da Nutrição/métodos , Psiquiatria/métodos , Dieta Saudável , Suplementos Nutricionais , Comportamento Alimentar/psicologia , Humanos , Transtornos Mentais/psicologia , Ciências da Nutrição/tendências , Psiquiatria/tendênciasAssuntos
Congressos como Assunto , Terapia por Estimulação Elétrica/métodos , Psiquiatria/métodos , Idoso , Idoso de 80 Anos ou mais , Encéfalo/fisiologia , Congressos como Assunto/organização & administração , Estimulação Encefálica Profunda/história , Estimulação Encefálica Profunda/métodos , Estimulação Encefálica Profunda/tendências , Terapia por Estimulação Elétrica/história , Terapia por Estimulação Elétrica/tendências , Eletroconvulsoterapia/história , Eletroconvulsoterapia/métodos , Eletroconvulsoterapia/tendências , Europa (Continente)/epidemiologia , Envelhecimento Saudável/fisiologia , História do Século XX , História do Século XXI , Humanos , Padrões de Prática Médica/história , Padrões de Prática Médica/tendências , Psiquiatria/história , Psiquiatria/tendênciasRESUMO
Parkinson disease (PD) is a progressive neurodegenerative disease with a higher prevalence of neuropsychiatric symptoms compared with the general population. Symptoms such as anxiety, depression, psychosis, impulse control disorders, and cognitive impairment cause a greater worsening of quality of life than even the motor symptoms that define PD. Despite the ubiquity and impact of neuropsychiatric symptoms, specialty mental healthcare is not routinely available, accessible, or integrated in most neurology practices. Currently, training in PD-specific mental healthcare is not standard in most programs, and the need for subspecialty-trained, mental healthcare providers will only increase over time, as the prevalence of PD will more than double by 2060. Many barriers limit extension of mental healthcare into existing models of integrated or multidisciplinary care and the community at large. Foundations and professional societies have played an important role in raising awareness of mental healthcare needs in PD; however, their initiatives to promote integrated or multidisciplinary care have traditionally focused on disciplines outside of mental health such as physical, occupational, and speech therapy. This article examines these issues and suggests strategies to better address mental healthcare needs for PD patients in the future.
Assuntos
Prestação Integrada de Cuidados de Saúde/tendências , Doença de Parkinson/complicações , Doença de Parkinson/psicologia , Doença de Parkinson/terapia , Psiquiatria/educação , Ansiedade/etiologia , Serviços Comunitários de Saúde Mental/normas , Depressão/etiologia , Humanos , Psiquiatria/tendências , Transtornos Psicóticos/etiologia , Qualidade de VidaRESUMO
This paper deals with the history of the relationship between the mind-body dualism and the epistemology of madness. Earlier versions of such dualism posed little problem in regard to the manner of their communication. The Cartesian view that mind and body did, in fact, name different substances introduced a problem of incommunicability that is yet to be resolved. Earlier views that madness may be related to changes in the brain began gaining empirical support during the 17th century. Writers on madness chose to resolve the mind-body problem differently Some stated that such communication was not needed; others, that mind was a redundant concept, as madness could be fully explained by structural changes in the brain; and yet others described psychological spaces for madness to inhabit as a symbolic conflict. The epistemology of the neurosciences bypasses the conundrum, as it processes all together the variables representing the brain, subjectivity, and behavior and bridges the "philosophical" gap by means of correlational structures.
Este artículo aborda la historia de la relación entre el dualismo mente-cuerpo y la epistemología de la locura. Las primeras versiones de dicho dualismo plantearon poco problema en relación a la manera en que ellas se comunicaban. La perspectiva cartesiana de que el cuerpo y la mente designan, de hecho, diferentes contenidos introdujo un problema de incomunicabilidad que aún no se ha resuelto. Durante el siglo XVII comenzaron a aparecer los datos empíricos que dieron sustento a los primeros planteamientos acerca de la relación entre la locura y los cambios cerebrales. Autores interesados en la locura decidieron resolver de diferente manera el problema mente-cuerpo. Algunos plantearon que dicha comunicación no era necesaria; otros, que la mente era un concepto redundante, ya que la locura podría explicarse totalmente por cambios estructurales del cerebro. Incluso, otros autores describieron espacios psicológicos para que la locura habitara como un conflicto simbólico. La epistemología de las neurociencias evita el enigma, al procesar juntas todas las variables que representan el cerebro, la subjetividad y las conductas, y une el hiato "filosófico" por medio de estructuras que se correlacionan.
Cet article traite de l'histoire des relations entre la dualité corps-esprit et l'épistémologie de la folie. Les versions antérieures d'une telle dualité ne posent guère de problème quant à leur façon de communiquer. L'idée cartésienne que le corps et l'esprit désignent, en fait, différents contenus, a mis en place un problème d'incommunicabilité qui n'est pas encore résolu. Au XVIIe siècle, des données empiriques ont soutenu l'existence d'un lien entre les maladies mentales et des modifications du cerveau. Des auteurs s'intéressant à la folie ont choisi de résoudre différemment le problème corps-esprit. Certains ont trouvé qu'une telle communication n'était pas nécessaire ; d'autres, que l'esprit est un concept redondant, les troubles mentaux pouvant être complètement expliqués par des changements structurels du cerveau ; et d'autres encore ont décrit l'espace psychologique de la folie comme un conflit symbolique. L'épistémologie des neurosciences contourne le dilemme en traitant ensemble toutes les variables représentant le cerveau, la subjectivité et le comportement et comble le vide « philosophique ¼ par des structures en corrélation.
Assuntos
Conhecimento , Relações Metafísicas Mente-Corpo , Filosofia Médica , Psiquiatria/métodos , Humanos , Relações Metafísicas Mente-Corpo/fisiologia , Psiquiatria/tendênciasAssuntos
Psiquiatria/tendências , Procedimentos Clínicos , Manual Diagnóstico e Estatístico de Transtornos Mentais , Endofenótipos , Saúde Holística , Humanos , Classificação Internacional de Doenças , Tratamento Psiquiátrico Involuntário , Transtornos Mentais/classificação , Participação do Paciente , Psiquiatria/éticaRESUMO
BACKGROUND: Public health crises in primary care and psychiatry have prompted development of innovative, integrated care models, yet undergraduate medical education is not currently designed to prepare future physicians to work within such systems. AIM: To implement an integrated primary care-psychiatry clerkship for third-year medical students. SETTING: Undergraduate medical education, amid institutional curriculum reform. PARTICIPANTS: Two hundred thirty-seven medical students participated in the clerkship in academic years 2015-2017. PROGRAM DESCRIPTION: Educators in psychiatry, internal medicine, and pediatrics developed a 12-week integrated Biopsychosocial Approach to Health (BAH)/Primary Care-Psychiatry Clerkship. The clerkship provides students clinical experience in primary care, psychiatry, and integrated care settings, and a longitudinal, integrated didactic series covering key areas of interface between the two disciplines. PROGRAM EVALUATION: Students reported satisfaction with the clerkship overall, rating it 3.9-4.3 on a 1-5 Likert scale, but many found its clinical curriculum and administrative organization disorienting. Students appreciated the conceptual rationale integrating primary care and psychiatry more in the classroom setting than in the clinical setting. CONCLUSIONS: While preliminary clerkship outcomes are promising, further optimization and evaluation of clinical and classroom curricula are ongoing. This novel educational paradigm is one model for preparing students for the integrated healthcare system of the twenty-first century.
Assuntos
Estágio Clínico/métodos , Prestação Integrada de Cuidados de Saúde/métodos , Atenção Primária à Saúde/métodos , Psiquiatria/métodos , Estudantes de Medicina , Estágio Clínico/tendências , Competência Clínica , Currículo/tendências , Prestação Integrada de Cuidados de Saúde/tendências , Feminino , Humanos , Masculino , Atenção Primária à Saúde/tendências , Psiquiatria/educação , Psiquiatria/tendênciasRESUMO
For over a century, researchers and educators have called for the integration of psychological science into medical school curricula, but such efforts have been impeded by barriers within medicine and psychology. In addressing these barriers, Psychology has re-examined its relationship to Medicine, incorporated psychological practices into health care, and redefined its parameters as a science. In response to interdisciplinary research into the mechanisms of bio-behavioral interaction, Psychology evolved from an ancillary social science to a bio-behavioral science that is fundamental to medicine and health care. However, in recent medical school curriculum innovations, psychological science is being reduced to a set of "clinical skills," and once again viewed as an ancillary social science. These developments warrant concern and consideration of new approaches to integrating psychological science in medical education.
Assuntos
Ciências do Comportamento/educação , Ciências do Comportamento/tendências , Currículo/tendências , Educação Médica/tendências , Psicologia/educação , Psicologia/tendências , Competência Clínica , Prestação Integrada de Cuidados de Saúde/tendências , Necessidades e Demandas de Serviços de Saúde/tendências , Humanos , Comunicação Interdisciplinar , Colaboração Intersetorial , Neuropsicologia/educação , Neuropsicologia/tendências , Psiquiatria/educação , Psiquiatria/tendências , Estados Unidos , Recursos HumanosRESUMO
OBJECTIVES: Neurofeedback is a technique that aims to teach a subject to regulate a brain parameter measured by a technical interface to modulate his/her related brain and cognitive activities. However, the use of neurofeedback as a therapeutic tool for psychiatric disorders remains controversial. The aim of this review is to summarize and to comment the level of evidence of electroencephalogram (EEG) neurofeedback and real-time functional magnetic resonance imaging (fMRI) neurofeedback for therapeutic application in psychiatry. METHOD: Literature on neurofeedback and mental disorders but also on brain computer interfaces (BCI) used in the field of neurocognitive science has been considered by the group of expert of the Neurofeedback evaluation & training (NExT) section of the French Association of biological psychiatry and neuropsychopharmacology (AFPBN). RESULTS: Results show a potential efficacy of EEG-neurofeedback in the treatment of attentional-deficit/hyperactivity disorder (ADHD) in children, even if this is still debated. For other mental disorders, there is too limited research to warrant the use of EEG-neurofeedback in clinical practice. Regarding fMRI neurofeedback, the level of evidence remains too weak, for now, to justify clinical use. The literature review highlights various unclear points, such as indications (psychiatric disorders, pathophysiologic rationale), protocols (brain signals targeted, learning characteristics) and techniques (EEG, fMRI, signal processing). CONCLUSION: The field of neurofeedback involves psychiatrists, neurophysiologists and researchers in the field of brain computer interfaces. Future studies should determine the criteria for optimizing neurofeedback sessions. A better understanding of the learning processes underpinning neurofeedback could be a key element to develop the use of this technique in clinical practice.
Assuntos
Neurorretroalimentação/métodos , Psiquiatria/métodos , Psiquiatria/tendências , Encéfalo/fisiopatologia , Mapeamento Encefálico/métodos , Eletroencefalografia , Humanos , Imageamento por Ressonância Magnética , Transtornos Mentais/diagnóstico , Transtornos Mentais/fisiopatologia , Transtornos Mentais/psicologia , Neurorretroalimentação/fisiologiaRESUMO
BACKGROUND: Iron plays an essential role in balancing the various metabolism in the body. It is also involved in the synthesis of several neurotransmitters. Nutritional iron deficiency is one of the most widespread worldwide; it poses a great health challenge due to the consequences it entails. OBJECTIVES: The aim of this research study is to explore the percentage of psychiatric patients who have a deficiency in iron. In addition, the study investigates the efficacy of iron administered by oral treatment on psychiatric symptomatology among iron deficient patients. The research study utilized the martial biological results, which involved the observation of the level of iron deficiency among the outpatients of a local psychiatrist and assessor from the period of January 2012 until December 2013. METHODS: Out of 412 patients, 295 were women and 117 men. The age of the participants ranged from 16 to 89years, with an average age of 45years. The only exclusion criterion was a patient's refusal or inability to take the prescribed iron assessment test. We considered a transferrin saturation coefficient (TSC)<30% and/or a serum ferritin level≤50ng/mL to be "indicative" of obvious iron deficiency, and a ferritin level between 51 and 100ng/mL to be "suggestive" of iron deficiency. A plasma ferritin assay was performed at least once on all of the participants prior to any proposed iron treatment. A calculation of the TSC in 138 patients was requested due to suspected iron deficiency despite a blood ferritin level of>100ng/ml. A single method was utilized in the various laboratories to analyse the blood samples to determine whether there was a deficiency in iron. Only those patients with blood ferritin levels ≤100ng/mL and/or a TSC of<30% (335 patients) were subsequently given exclusively an oral iron treatment prescribed on its own or as a supplement or simultaneously with psychotropic treatment. The daily administered dose of elemental iron varied between 50 and 200mg a day. RESULTS: About half of the women - 145 (35.19% of the subjects) - and 15 men (3.64% of the subjects) certainly had a deficiency in iron (blood ferritin level≤50ng/mL). Ninety women and 24 men (27.6% of the subjects) had blood ferritin levels between 51 and 100ng/mL indicating iron deficiency, and 28 women and 33 men (14.8% of the subjects) had a TSC of<30% despite a blood ferritin level of>100ng/mL. Overall, 335 patients (81.3% of the subjects) showed an iron deficiency based on the criteria we set. In the remaining 77 patients (18.7% of the subjects), all of them had blood ferritin levels>100ng/mL and some had TSC≤30%, while the remaining patients' TSC was unknown because it was not measured. The results indicated that there is an iron deficiency in 198 out of 240 patients suffering mostly from mood and behavioural disorders, in 101 out of 126 patients suffering mostly from anxiety disorders, in 18 out of 27 patients suffering mostly from sleep disorders, in 14 out of 15 patients suffering mostly from delusions of persecution, and in the 4 patients suffering mostly from burn out. There was evidence of regression/remission of psychiatric symptoms in 193 responsive patients whereas the remaining 142 patients were considered non-responsive. In the responsive patient category, 37 participants were treated with just iron, 52 received iron supplemented to the initial psychotropic treatment which was not fully effective, and 104 patients were treated with iron and prescribed psychotropic drugs simultaneously. The iron treatment seems to bring about a reduction - particularly through its mono-aminergic neurotransmitter synthesis-promoting action - in hyperemotivity, anxiety, irritability, aggressiveness, sadness, anhedonia, apathy, asthenia, sleep disorders, dysautonomia symptoms, eating disorders, restless-leg syndrome, cognitive performance and the likelihood of resorting to psychiatric admission. A daily elemental iron dose intake between 50 and 200mg/day by deficient patients appears to likely enhance the effects of the psychotropic drugs and even to act as an actual antidepressant. Many patients who received a prescription for iron and antidepressants showed few side effects related to antidepressants and a small number required psychiatric hospitalization. Patients considered unresponsive to iron therapy were those who left the study, were not assessed because the study's timeframe ended, still had an iron deficiency because they did not continuously take the medication, or suffered from somatic diseases which explains their resistance to treat the low iron level (nutritional imbalance, digestive or urinary or gynecological or iatrogenic diseases, sleep apnea). CONCLUSION: Our clinical observation of two years in a local psychiatrist's clinic revealed that over 80% of patients had iron deficiency. Although the low iron level cannot explain all physical and psychiatric symptoms in patients, it is useful to note that more than half of the iron deficient patients responded favorably after an oral treatment of iron. This result leads to further investigation of the level of iron in psychiatric patients and to reconsider the iron range placed by the laboratories. In addition, it is crucial not to eliminate the possibility of iron deficiency in psychiatric patients. Further research studies are needed to set more specific and detailed criteria to determine the range of iron deficiency in order to support the findings of this study and optimize the care given to patients suffering from various disorders and psychiatric syndromes.